Sr. Manager, QA Lot Disposition
- Employer
- Sutro Biopharma, Inc
- Location
- San Carlos, CA
- Salary
- $170,000 - $175,000
- Start date
- Aug 19, 2024
View more categoriesView less categories
- Discipline
- Quality, Quality Assurance
- Required Education
- Bachelors Degree
- Position Type
- Full time
- Hotbed
- Biotech Bay, Best Places to Work
Job Details
- Perform Lot Release Disposition of Internally and Externally produced products.
- Represent QA team leadership to respond to CMC deliverables on product disposition externally and in some cases, internally
- Coordinate with External Quality Assurance to compile and review all documentation to perform Quality Release of Externally produced Products
- Assist in the completion and maintenance of CMO/CTO Quality Agreements
- Actively support the development, implementation, and maintenance of Sutro quality management systems & applicable SOP’s
- Perform reviews of cGMP documentation, both at Sutro and contract organizations.
- Review and approve completed batch documentation for cGMP production, including QC documentation of release and in-process testing
- Lead investigation and resolution of cGMP or procedural compliance failures, as well as work with staff from other departments to resolve compliance issues found during the Quality review.
- Release raw materials and batches/lots for further manufacturing, clinical trials, and commercial distribution
- Oversee and perform training of personnel to ensure compliance and conformance to Sutro’s requirements
- Develop, apply, revise, and maintain quality assurance protocols and methods for processing materials into partially finished or finished products
- Perform analysis of reports and production data to identify trends and recommend updates or changes to quality standards and procedures when necessary
- Participation in the ERP and Quality System implementation, training, and maintenance activities
- May ensure compliance to in-house and/or external specifications and standards, (i.e. GLP, GMP, ISO, Six Sigma)
- Internal Collaborations – Manufacturing, Quality Control, Quality Operations, Process Development, Analytical Development, Supply Chain, Regulatory Affairs, Alliance Management, among others
- External Collaborations – Contract Manufacturing Organizations (CMOs), Contract Testing Organizations (CTOs), Partnered Program Companies
- 10+ years of industry experience with 8+ years experience in Quality Assurance/Quality Systems related experience in a cGMP pharma/biologics regulated manufacturing environment is required
- Possess a working knowledge of 21 CFR FDA, EU and ICH guidelines
- Bachelor’s degree or higher in a relevant scientific area is strongly preferred
- Relevant Quality Systems experience including Supplier and CMO/CTO Management, Raw Material Review Board Team Management, Change Control, Documentation Control, Training and Raw Material/Final Product Release
- Skilled in evaluating and implementing solutions for regulatory compliance guidelines
- Demonstrated ability to work accurately, follow instructions/schedules/timelines and handle multiple priorities
- Knowledge and ability to sufficiently train others on regulatory compliance issues pertaining to external requirements
- Strong interpersonal skills and ability to work with others in a positive “can do” and collaborative manner
- Balanced decision making that demonstrates critical thinking
- Able to establish priorities and maintain progress even under uncertain circumstances
- Strong verbal and written communication skills are essential
- Strong communication, prioritization and organizational skills
- Requires thorough knowledge of cGMPs and regulations applicable to the FDA and comparable international regulatory agencies
- Ability to utilize multiple word-processing and database applications
Company
Sutro Biopharma, Inc., is a clinical-stage company relentlessly focused on the discovery and development of precisely designed cancer therapeutics, transforming what science can do for patients. Sutro’s fit-for-purpose technology, including cell-free XpressCF®, provides the opportunity for broader patient benefit and an improved patient experience. Sutro has multiple clinical stage candidates, including luveltamab tazevibulin, or luvelta, a registrational-stage folate receptor alpha (FolRα)-targeting ADC in clinical studies. A robust pipeline, coupled with high-value collaborations and industry partnerships, validates our continuous product innovation. Sutro is headquartered in South San Francisco. For more information, follow Sutro on social media @Sutrobio, or visit www.sutrobio.com.
Stock Symbol: STRO
Bill Newell, CEO Interviewed by Brad Loncar, Founder, Biotech TV – “Sutro Biopharma’s CEO on ADCs, non-cell protein synthesis, and more" - view it here
- Website
- http://www.sutrobio.com/
- Phone
- 650.881.6500
- Location
-
111 Oyster Point Blvd
South San Francisco
California
94080
US
Get job alerts
Create a job alert and receive personalized job recommendations straight to your inbox.
Create alert